IS5603A - Aðferð til framleiðslu á 5-lípoxýgenasa lötum meðmargvísleg heterósýklísk hringkerfi - Google Patents

Aðferð til framleiðslu á 5-lípoxýgenasa lötum meðmargvísleg heterósýklísk hringkerfi

Info

Publication number
IS5603A
IS5603A IS5603A IS5603A IS5603A IS 5603 A IS5603 A IS 5603A IS 5603 A IS5603 A IS 5603A IS 5603 A IS5603 A IS 5603A IS 5603 A IS5603 A IS 5603A
Authority
IS
Iceland
Prior art keywords
lipoxygenase
highly
production
heterocyclic ring
ring system
Prior art date
Application number
IS5603A
Other languages
English (en)
Inventor
Norris Timothy
Francis Lambert Johan
Elizabeth Hnatow Megan
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS5603A publication Critical patent/IS5603A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
IS5603A 1999-08-31 2000-08-25 Aðferð til framleiðslu á 5-lípoxýgenasa lötum meðmargvísleg heterósýklísk hringkerfi IS5603A (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15161599P 1999-08-31 1999-08-31

Publications (1)

Publication Number Publication Date
IS5603A true IS5603A (is) 2001-03-01

Family

ID=22539529

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5603A IS5603A (is) 1999-08-31 2000-08-25 Aðferð til framleiðslu á 5-lípoxýgenasa lötum meðmargvísleg heterósýklísk hringkerfi

Country Status (33)

Country Link
US (1) US6346624B1 (is)
EP (1) EP1081143A1 (is)
JP (1) JP2001106682A (is)
KR (1) KR20010050256A (is)
CN (1) CN1286250A (is)
AP (1) AP2000001910A0 (is)
AU (1) AU5360300A (is)
BG (1) BG104731A (is)
BR (1) BR0003945A (is)
CA (1) CA2317097A1 (is)
CZ (1) CZ20003158A3 (is)
EA (1) EA200000801A1 (is)
EE (1) EE200000512A (is)
GT (1) GT200000142A (is)
HR (1) HRP20000564A2 (is)
HU (1) HUP0003439A3 (is)
ID (1) ID27129A (is)
IL (1) IL138087A0 (is)
IS (1) IS5603A (is)
MA (1) MA26751A1 (is)
NO (1) NO20004313L (is)
NZ (1) NZ506632A (is)
OA (1) OA11452A (is)
PA (1) PA8499701A1 (is)
PE (1) PE20010520A1 (is)
PL (1) PL342281A1 (is)
SG (1) SG87146A1 (is)
SK (1) SK12872000A3 (is)
SV (1) SV2002000159A (is)
TN (1) TNSN00177A1 (is)
TR (1) TR200002529A2 (is)
UY (1) UY26314A1 (is)
ZA (1) ZA200004435B (is)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6669042B1 (en) * 2002-09-30 2003-12-30 Hewlett-Packard Development Company, L.P. Integrated positioning and locking device
US7674811B2 (en) 2006-03-14 2010-03-09 Ranbaxy Laboratories Limited 5-lipoxygenase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063928A (en) * 1994-10-18 2000-05-16 Pfizer Inc 5-lipoxygenase inhibitors
SK281577B6 (sk) 1994-10-18 2001-05-10 Pfizer Inc. Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze
US5883106A (en) * 1994-10-18 1999-03-16 Pfizer Inc. 5-lipoxygenase inhibitors
US6239285B1 (en) * 1998-02-06 2001-05-29 Pfizer Inc Process for making 5-lipoxygenase inhibitors having varied heterocyclic ring systems

Also Published As

Publication number Publication date
KR20010050256A (ko) 2001-06-15
CN1286250A (zh) 2001-03-07
EE200000512A (et) 2001-04-16
EA200000801A1 (ru) 2001-04-23
BR0003945A (pt) 2001-04-03
OA11452A (en) 2003-12-08
CA2317097A1 (en) 2001-02-28
ZA200004435B (en) 2002-02-28
MA26751A1 (fr) 2004-12-20
CZ20003158A3 (cs) 2001-09-12
HUP0003439A3 (en) 2002-08-28
NZ506632A (en) 2002-02-01
HU0003439D0 (en) 2000-08-30
US6346624B1 (en) 2002-02-12
SG87146A1 (en) 2002-03-19
HRP20000564A2 (en) 2001-12-31
JP2001106682A (ja) 2001-04-17
TR200002529A2 (tr) 2001-04-20
PE20010520A1 (es) 2001-04-28
NO20004313D0 (no) 2000-08-30
ID27129A (id) 2001-03-01
GT200000142A (es) 2002-02-19
SK12872000A3 (sk) 2001-11-06
EP1081143A1 (en) 2001-03-07
HUP0003439A2 (hu) 2001-08-28
NO20004313L (no) 2001-03-01
AU5360300A (en) 2001-03-08
IL138087A0 (en) 2001-10-31
AP2000001910A0 (en) 2000-09-30
BG104731A (en) 2001-09-28
SV2002000159A (es) 2002-01-23
UY26314A1 (es) 2001-04-30
PA8499701A1 (es) 2001-12-14
PL342281A1 (en) 2001-03-12
TNSN00177A1 (fr) 2005-11-10

Similar Documents

Publication Publication Date Title
NO20021855L (no) Rapid aerogelproduksjonsprosess
IS5982A (is) Aðferð til framleiðslu á 5-sýanóþalíði
AR024800A1 (es) Proceso de produccion de fenil-alcanos
IS2711B3 (is) Aðferð til framleiðslu á amín platínu komplexum
IS6834A (is) Aðferð til framleiðslu á amlódipín maleati
IS2697B (is) Aðferð til framleiðslu á sítalóprami
IS5862A (is) Aðferð til framleiðslu á sítalóprami
IS2343B (is) Aðferð til framleiðslu á sítalóprami
IS5596A (is) Aðferð til framleiðslu á fituefnablöndu
IS6487A (is) Aðferð til framleiðslu á Sítalóprami
IS2261B (is) Aðferð til framleiðslu á 5-sýanóþalíði
IS4687A (is) Aðferð við framleiðslu á lyktarlitlum pólýeter pólýólum
IS7239A (is) Aðferð til framleiðslu á essítalóprami
HK1048627A1 (en) Method for the production of adrenaline.
IS5538A (is) Ný aðferð til framleiðslu á ketamíni
IS5604A (is) Aðferð til framleiðslu á 5-lípoxýgenasa lötum meðmargvísleg heterósýklísk hringkerfi
IS5603A (is) Aðferð til framleiðslu á 5-lípoxýgenasa lötum meðmargvísleg heterósýklísk hringkerfi
ZA985918B (en) Process for the production of indole derivatives.
IL138787A0 (en) Process for the production of organic compounds in a membrane reactor
HUP0202530A2 (en) Method for the production of phosphonomethylglycin
FR2798483B1 (fr) Procede de production automatique de specifications
IS5019A (is) Aðferð til framleiðslu á hýdroxamsýrum
IL144809A0 (en) Method for the production of aliphatic fluoroformates
FI991542A (fi) Menetelmä moniarvoisten alkoholien valmistusprosessin ohjaamiseksi
IS4707A (is) Aðferð til framleiðslu á díoxóazabísýklóhexönum